NSEAcquisition6 Oct 2026 · 6 Oct 2026, 07:53 pm

Acquisition

Krishna Institute of Medical Sciences Limited · KIMS

✦ AI SummaryM&A

Krishna Institute of Medical Sciences Limited has informed the Exchange about the acquisition of 51% equity stake in Sarvottam Health Care Private Limited (Kakinada) for up to Rs. 80.00 Cr.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition

Attachments (1)

📄

KIMS_06102026195302_Disclosure_to_Stock_Exchanges-06102026-Sarvottam.pdf

pdf

Download →
View document text
06th October, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition of 51% Equity Stake in Sarvottam Health Care Private Limited (Kakinada), an O & M entity by investing upto Rs. 80.00 Cr – Reg. Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”) at its meeting held on today, i.e. 06th October, 2026 has approved the proposal for acquisition upto 51% equity stake of the total paid-up equity share capital of Sarvottam Health Care Private Limited (Kakinada), an O & M entity upto by investing Rs. 80.00 Cr. We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as an Annexure-1 to this letter. Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE -1 a Name of the target entity, details in brief Name of the target entity: Sarvottam Health care such as size, turnover, etc., Private Limited. Details in brief: Sarvottam Health Care Private Limited (the ‘Company’) commenced operations in 2010 with an initial capacity of 50 beds under the brand name “Trust Multi Speciality Hospital”, with a present capacity of 183 beds focusing on providing quality healthcare services to the Kakinada region. Recognizing the growing demand for advanced medical care in East Godavari district, the management invested in constructing a new state-of-the-art hospital campus. In 2021, hospital inaugurated a state of art hospital building comprising of a cellar + ground floor with 7 upper floors (G+7 structure), with a total built-up area of approximately 9847.23 square mtrs on a company owned land ad measuring 3001 .36 Sq Yards and commissioned additional 183 beds. This makes Trust Hospitals as one of the largest and most comprehensive healthcare providers in Kakinada. (Rs. in Crore) FY 2025-26 Turnover: 84.83 PAT: 70.55 Networth: 50.30 b Whether the acquisition would fall within Acquisition of equity shares does not fall within related party transaction(s) and whether the definition of Related Party Transaction. the promoter / promoter group / group companies have any interest in the entity being acquired? If yes, nature of Interest and details thereof and whether the same is done at "Arms length": c Industry to which the entity being acquired Healthcare Industry belongs: d Objects and effects of acquisition (including KIMS being the O & M Partner of the target entity but not limited to, disclosure of reasons for has decided to acquire upto 51% of the total equity acquisition of target entity, if its business is stake as a strategic investment. outside the main line of business of the listed entity e Brief details of any governmental or regulatory Not Applicable. approvals required for the acquisition: f Indicative time period for completion of the On or before 31.10.2026 acquisition g Consideration - whether cash consideration Cash. or share swap and details of the same: h Cost of acquisition or the price at which the The shares will be acquired based on the valuation shares are acquired; report issued by BDO Valuation Advisory LLP dated 05th October, 2026, for an aggregate consideration up to ₹80.00 Crore (Rupees Eighty Crore only). i Percentage of shareholding/control KIMS will acquire upto 21,72,713 equity shares of acquired and/or number of shares Rs. 10 each representing 51.00% of the equity acquired; share capital of Target Company, for an aggregate consideration of up to ₹80.00 Crore (Rupees Eighty Crore only). j Brief background about the entity acquired Brief background about the entity acquired: As in terms of products/line of business mentioned in serial no. (a) acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence, and any other Date of Incorporation: 19-04-2011 significant information (in brief): History of last 3 years Total Turnover of the Company: Particulars Amount in Crores FY26 84.83 FY25 81.38 FY24 74.36 Presence: Kakinada, Andhra Pradesh - India Other Significant Information: please refer to the aforementioned.